Quality of Herbal Medicinal Products - Current EMA/HMPC Q&A Document
On the 20th of October 2010, the European Medicines Agency (EMA) published the document 41500/2010 containing interesting Questions and Answers on quality of herbal medicinal products/traditional herbal medicinal products.
In total, you can read answers to 26 different questions on the following fields:
- Specification of the finished product
- Testing
- Contaminants (Mycotoxins)
- Microbiological quality
- Fumigants
- Manufacture
- Quality of water
- Stability
Stability has been the most asked subject with 12 questions.
Here are 2 examples:
Question 25:
Is one type of chromatographic fingerprint sufficient for stability testing of the finished product?
Answer:
Yes, in most cases. If more than one group of constituents is known to contribute to the activity of the active substance, the fingerprints should cover all the groups.
Question 26:
Are stability overages for herbal active substances acceptable?
Answer:
In general, as the whole herbal substance/preparation is considered as the active substance, stability overages wouldn't be acceptable. However, stability overages would be acceptable for standardized extracts if justified.
You may want to find more - here's the complete Q&A document..
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation